Photo provided by AdvaMed
One of the medical technology industry’s headlining annual events, The MedTech Conference, powered by Advanced Medical Technology Association, will gather in Philadelphia from September 24 to 26. The rapidly growing conference will bring 3,000 policymakers, business executives and innovators to the Pennsylvania Convention Center. It’s a prime opportunity to mix and mingle with professionals from both the private and public sectors in Philadelphia.
The natural fit was brokered by the PHLCVB Convention Sales team and PHL Life Sciences Executive Director Bonnie Grant, who has long lobbied for the group, based in Washington, D.C., to appear in the city. The conference, which has existed since 2009, is making its first appearance in Philadelphia.
“We are thrilled that MedTech will be in Philadelphia for the first time. We not only want science and medical device visionaries to be in Philadelphia, but to spotlight the innovation happening throughout our region,” Grant said.
Featured speakers include Commissioner of the U.S. Food and Drug Administration Scott Gottlieb, MD, Facebook Vice President of Engineering, Building 8 Regina E. Dugan, and Salesforce Chief Medical Officer Joshua Newman, MD, MSHS. The hybrid of tech and medical leaders will result in an engaging week of knowledge sharing.
Key in landing MedTech was Philadelphia advocate and current AdvaMed Executive Vice President Ray Briscuso, who worked at Life Sciences Conference Group, LLC for more than a decade. Ray is credited with growing BIO from 2,000 annual attendees to more than 18,000. BIO returns to Philadelphia in 2019.
In March 2018, AdvaMed announced a transition that makes the association full owner and operator of The MedTech Conference.
Photo Courtesy Einstein Healthcare Network
In what is poised to be a bellwether move, two major Philadelphia healthcare institutions are joining forces. Thomas Jefferson University and Einstein Healthcare Network have signed a letter of intent, designed to further the mission of both organizations and to reach more patients in the Greater Philadelphia region.
With a focus on bringing academic research to life and expanding the pool of highly-qualified clinical professionals, the merger creates a substantial network of 18 health systems. In 2017, Jefferson earned approximately $4.8 billion in revenue. Consistently ranked as one of the country’s best hospitals, Jefferson is responsible for close to 1.4 million outpatient visits annually.
Jefferson, which pioneers key clinical areas like orthopedics, neurology, ophthalmology and cancer research, is headed by President and CEO Stephen K. Klasko, MD. The business and thought leader is never quiet about his views on the healthcare industry. With a pulse on technology and patient-centered care, Dr. Klasko frequently adds relevant and timely dialogue to meetings and conventions in the Philadelphia region. This year, he will keynote the International Microwave Symposium (IMS) at the Pennsylvania Convention Center. Hear more about his plans for Jefferson, which remains in a period of due diligence with Einstein Healthcare, during “The Hitchhiker’s Guide to the Healthcare Galaxy” at the June 10-15 convention.
BIO 2019, which involves cooperation from various government and association partners, is set to bring a significant economic boost to Philadelphia next year. Preparations are already underway, as the region activates the ecosystem for an international audience. Philadelphia will have a major presence this year at BIO 2019 in Boston, June 4 to 8.
PHL Life Sciences will partner with Life Sciences Pennsylvania, along with the City of Philadelphia’s Commerce Department, Select Greater Philadelphia and the University City Science Center on a pavilion at the registration area of BIO 2019, considered prime real estate.
Looking back, the results of BIO 2015 were impressive, with 29,279 partnering meetings and 15,858 industry leaders in attendance. Those numbers continue to grow and Philadelphia offers a rich pool of talent and long-term business opportunities.
Partnering with BIO continues to be mutually beneficial for both the city and the global trade organization, with patrons embracing some of the city’s finest attractions outside of the venue. The four-year gap between conventions has given Philadelphia an opportunity to add world class restaurants, new historical museums and transportation upgrades.
About 5,500 physicians of nuclear medicine, molecular imaging and a variety of other clinical researchers, will convene in Philadelphia between June 23 and 26, 2018.
The Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) annual gathering, curated by Chairman of the SNMMI Program Committee Dr. Umar Mahood, will take place during the first days of summer in Philadelphia. Participants will be able to spill out into neighboring beer gardens, Old City Historic District and a vibrant nightlife scene. With unconventional programs like “Drink and Think”, SNMMI’s schedule of events has been designed to appreciate everything the city has to offer. A “Hot Trot 5K” will also give visitors an opportunity to see the city in bloom.
Proximity to leading researchers and an esteemed medical community were selling points on Philadelphia for SNMMI. Penn, The Children’s Hospital of Philadelphia, a major pharma presence, and German medical imaging and diagnostics company Siemens are all conveniently located in or around the country’s fifth largest city in terms of population size. Siemens’ Healthineers Division, based in Malvern, Pa., recently launched an IPO on the Frankfurt Stock Exchange, a certain conversation topic during the event. For more information, visit snmmi.org.
PHL Life Sciences continues to work with Meeting Professionals International (MPI), the largest meeting and event industry association worldwide, with participation on a task force for education and community support, known as MPI-MD.
The MPI-MD Advisory Council is assessing current industry standards and will work to design and implement new medical/pharma initiatives, across the board. Representing PHL Life Sciences will be Executive Director Bonnie Grant, who also serves on the Professional Convention Management Association (PCMA) Medical Meetings Task Force. These coveted committee positions keep Philadelphia front and center as a medical meetings destination.
Founded in 1972, MPI has evolved from a niche community to a global entity with more than 17,000 engaged members from 19 countries. For more information, please visit the homepage.
The 11th annual Pharma and Biotech Project & Portfolio Management conference (PPM) brings 20 speakers, including Sanjeev Gupta, to Philadelphia’s University City Hotel on May 22 and 23. Ideas on how to operationalize R&D strategy and moving the needle for patient-led innovation will be addressed. For more information or to sign up, please visit here.